Beck Mack & Oliver’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.7M | Sell |
180,910
-5,730
| -3% | -$409K | 0.28% | 47 |
|
|
2025
Q4 | $11.5M | Hold |
186,640
| – | – | 0.21% | 52 |
|
|
2025
Q3 | $11M | Buy |
186,640
+600
| +0.3% | +$35K | 0.2% | 51 |
|
|
2025
Q2 | $10.8M | Sell |
186,040
-780
| -0.4% | -$44.1K | 0.21% | 53 |
|
|
2025
Q1 | $9.28M | Sell |
186,820
-14,428
| -7% | -$738K | 0.19% | 60 |
|
|
2024
Q4 | $9.01M | Buy |
201,248
+37,348
| +23% | +$1.77M | 0.17% | 59 |
|
|
2024
Q3 | $7.88M | Sell |
163,900
-2,020
| -1% | -$97.4K | 0.15% | 64 |
|
|
2024
Q2 | $8.45M | Sell |
165,920
-13,840
| -8% | -$758K | 0.18% | 62 |
|
|
2024
Q1 | $9.76M | Hold |
179,760
| – | – | 0.2% | 57 |
|
|
2023
Q4 | $10.1M | Sell |
179,760
-2,650
| -1% | -$150K | 0.24% | 54 |
|
|
2023
Q3 | $11.3M | Sell |
182,410
-1,000
| -0.5% | -$63.3K | 0.29% | 53 |
|
|
2023
Q2 | $10.8M | Sell |
183,410
-50
| -0% | -$3.18K | 0.28% | 53 |
|
|
2023
Q1 | $13.5M | Sell |
183,460
-676
| -0.4% | -$52.2K | 0.39% | 49 |
|
|
2022
Q4 | $13.4M | Sell |
184,136
-200
| -0.1% | -$15.8K | 0.39% | 51 |
|
|
2022
Q3 | $15.4M | Sell |
184,336
-1,000
| -0.5% | -$86K | 0.5% | 45 |
|
|
2022
Q2 | $14.8M | Buy |
185,336
+898
| +0.5% | +$87.2K | 0.44% | 50 |
|
|
2022
Q1 | $19.2M | Buy |
184,438
+512
| +0.3% | +$42.4K | 0.48% | 44 |
|
|
2021
Q4 | $13.8M | Buy |
183,926
+1,260
| +0.7% | +$88.2K | 0.33% | 51 |
|
|
2021
Q3 | $11.8M | Sell |
182,666
-3,560
| -2% | -$218K | 0.31% | 53 |
|
|
2021
Q2 | $11.3M | Sell |
186,226
-1,300
| -0.7% | -$76.9K | 0.3% | 54 |
|
|
2021
Q1 | $10.1M | Sell |
187,526
-1,800
| -1% | -$97.9K | 0.31% | 54 |
|
|
2020
Q4 | $9.12M | Sell |
189,326
-1,200
| -0.6% | -$53K | 0.3% | 54 |
|
|
2020
Q3 | $7.47M | Buy |
190,526
+7,360
| +4% | +$268K | 0.27% | 54 |
|
|
2020
Q2 | $5.88M | Sell |
183,166
-17,080
| -9% | -$594K | 0.22% | 56 |
|
|
2020
Q1 | $6.8M | Sell |
200,246
-10,448
| -5% | -$418K | 0.3% | 52 |
|
|
2019
Q4 | $10.1M | Sell |
210,694
-4,500
| -2% | -$217K | 0.33% | 54 |
|
|
2019
Q3 | $10.7M | Sell |
215,194
-3,800
| -2% | -$194K | 0.38% | 50 |
|
|
2019
Q2 | $11.7M | Sell |
218,994
-2,700
| -1% | -$141K | 0.41% | 50 |
|
|
2019
Q1 | $11.7M | Sell |
221,694
-7,600
| -3% | -$396K | 0.42% | 49 |
|
|
2018
Q4 | $10.8M | Sell |
229,294
-2,340
| -1% | -$122K | 0.43% | 49 |
|
|
2018
Q3 | $13.4M | Sell |
231,634
-20,880
| -8% | -$1.16M | 0.42% | 50 |
|
|
2018
Q2 | $13.7M | Buy |
252,514
+50
| +0% | +$2.48K | 0.46% | 49 |
|
|
2018
Q1 | $11.9M | Buy |
+252,464
| New | +$12.6M | 0.4% | 52 |
|
Other funds holding NTR
VCM
Beck Mack & Oliver's NTR Position: Q1 2026 in Review
Beck Mack & Oliver reduced its Nutrien (NTR) stake by 3.1% in Q1 2026, selling an estimated $409K and leaving 180,910 shares worth $13.7M. The position accounts for 0.28% of the portfolio, ranked #47.
Beck Mack & Oliver first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. The position peaked at $19.2M in Q1 2022. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.
- Beck Mack & Oliver held 180,910 shares of Nutrien worth $13.7M as of Q1 2026.
- Beck Mack & Oliver sold 5,730 Nutrien shares in Q1 2026, an estimated $409K.
- Nutrien made up 0.28% of Beck Mack & Oliver's portfolio in Q1 2026, its #47 holding.
- Beck Mack & Oliver first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
- Beck Mack & Oliver's Nutrien position peaked at $19.2M in Q1 2022.
- 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.
Based on Beck Mack & Oliver's 13F filing for Q1 2026, filed 12 May 2026.